BEGIN:VCALENDAR VERSION:2.0 PRODID:-//CITI Program - ECPv6.17.5//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:CITI Program X-ORIGINAL-URL:https://about.citiprogram.org X-WR-CALDESC:Events for CITI Program REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20270314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20271107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20260929T093000 DTEND;TZID=America/New_York:20260929T103000 DTSTAMP:20260901T155620Z CREATED:20260901T155620Z LAST-MODIFIED:20260901T155620Z UID:62640-1790674200-1790677800@about.citiprogram.org SUMMARY:Free Webinar Replay - NIH Biospecimens Rule DESCRIPTION:NIH Biospecimens Rule\nTuesday\, September 29\, 2026 at 9:30 a.m. ET\nThis previously played webinar reviews how the NIH Policy on Enhancing Security Measures for Human Biospecimens follows a broader federal trend toward tightening physical and operational controls on sensitive personal data\, especially in light of DOJ’s bulk-data rule and federal concerns about unauthorized foreign access. This webinar introduces the policy’s rationale\, situates it within NIH’s existing data and research-governance framework\, and outlines the safeguards NIH now expects from institutions handling human specimens. Learners gain a grounded understanding of what the policy covers\, why it emerged\, and what early steps they should consider. \nRegister for additional free live webinars and available webinar replays. \n\n \n \n\n\n \n\n \n \n \n \n Register For This Webinar\n \n \n \n \n\n\n \n \n \n \n First Name\n \n \n \n \n \n Last Name\n \n \n \n \n\n \n \n \n Email Address\n \n \n \n \n \n Organization\n \n \n \n\n \n\n \n \n \n Please share your question for the presenter(s) here:\n \n \n \n \n\n \n \n \n May we contact you about new CITI Program content and services after the webinar?\n \n \n \n \n Yes\n \n \n \n No\n \n \n\n \n \n\n \n Register Now\n \n\n \n Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy. URL:https://about.citiprogram.org/event/free-webinar-replay-nih-biospecimens-rule/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/02/citi-program-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260929T110000 DTEND;TZID=America/New_York:20260929T120000 DTSTAMP:20260901T155628Z CREATED:20260901T155628Z LAST-MODIFIED:20260901T155628Z UID:62645-1790679600-1790683200@about.citiprogram.org SUMMARY:Free Webinar Replay - A Behavioral Approach to Compliance DESCRIPTION:A Behavioral Approach to Compliance\nTuesday\, September 29\, 2026 at 11:00 a.m. ET\nThis previously released webinar teaches how behavioral science can enhance compliance programs by exploring human decision-making drivers\, including how to apply a framework to show how to design compliant behaviors\, how to create behaviorally informed strategies\, and how to draw on on practical examples from the #complianceinthewild case studies. \nRegister for additional free live webinars and available webinar replays. \n\n \n \n\n\n \n\n \n \n \n \n Register For This Webinar\n \n \n \n \n\n\n \n \n \n \n First Name\n \n \n \n \n \n Last Name\n \n \n \n \n\n \n \n \n Email Address\n \n \n \n \n \n Organization\n \n \n \n\n \n\n \n \n \n Please share your question for the presenter(s) here:\n \n \n \n \n\n \n \n \n May we contact you about new CITI Program content and services after the webinar?\n \n \n \n \n Yes\n \n \n \n No\n \n \n\n \n \n\n \n Register Now\n \n\n \n Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy. URL:https://about.citiprogram.org/event/free-webinar-replay-a-behavioral-approach-to-compliance/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/02/citi-program-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260929T130000 DTEND;TZID=America/New_York:20260929T140000 DTSTAMP:20260901T155647Z CREATED:20260901T155647Z LAST-MODIFIED:20260901T155647Z UID:62648-1790686800-1790690400@about.citiprogram.org SUMMARY:Free Webinar Replay - Being Creative when Applying the IRB Exemptions: Part 2 DESCRIPTION:Being Creative when Applying the IRB Exemptions: Part 2\nTuesday\, September 29\, 2026 at 1:00 p.m. ET\nThis previously released webinar discusses that IRB exemptions are underutilized because many institutions take a very conservative approach when applying them. Through discussion and examples\, this presentation discusses the concept of exemptions and the role they play in regulated and unregulated research. This presentation also points out flexibilities in applying the exemption criteria in categories 4-8 that are often overlooked. \nRegister for additional free live webinars and available webinar replays. \n\n \n \n\n\n \n\n \n \n \n \n Register For This Webinar\n \n \n \n \n\n\n \n \n \n \n First Name\n \n \n \n \n \n Last Name\n \n \n \n \n\n \n \n \n Email Address\n \n \n \n \n \n Organization\n \n \n \n\n \n\n \n \n \n Please share your question for the presenter(s) here:\n \n \n \n \n\n \n \n \n May we contact you about new CITI Program content and services after the webinar?\n \n \n \n \n Yes\n \n \n \n No\n \n \n\n \n \n\n \n Register Now\n \n\n \n Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy. URL:https://about.citiprogram.org/event/free-webinar-replay-being-creative-when-applying-the-irb-exemptions-part-2/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/02/citi-program-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260929T140000 DTEND;TZID=America/New_York:20260929T150000 DTSTAMP:20260901T155657Z CREATED:20260901T155657Z LAST-MODIFIED:20260901T155657Z UID:62651-1790690400-1790694000@about.citiprogram.org SUMMARY:Free Webinar Replay - Seven Elements of an Effective Compliance Program: What Research Administrators Need to Know DESCRIPTION:Seven Elements of an Effective Compliance Program: What Research Administrators Need to Know\nTuesday\, September 29\, 2026 at 2:00 p.m. ET\nThis previously released webinar is tailored for IRB\, IACUC\, and sponsored program research administrators. This webinar explores the seven key elements that ensure regulatory adherence\, mitigate administrative risks\, and promote ethical research administration. This session provides practical strategies and case studies as to how to strengthen research compliance programs from an administrative perspective\, operationalize mission\, regulations\, and guidance\, and foster a culture of integrity. \nRegister for additional free live webinars and available webinar replays. \n\n \n \n\n\n \n\n \n \n \n \n Register For This Webinar\n \n \n \n \n\n\n \n \n \n \n First Name\n \n \n \n \n \n Last Name\n \n \n \n \n\n \n \n \n Email Address\n \n \n \n \n \n Organization\n \n \n \n\n \n\n \n \n \n Please share your question for the presenter(s) here:\n \n \n \n \n\n \n \n \n May we contact you about new CITI Program content and services after the webinar?\n \n \n \n \n Yes\n \n \n \n No\n \n \n\n \n \n\n \n Register Now\n \n\n \n Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy. URL:https://about.citiprogram.org/event/free-webinar-replay-seven-elements-of-an-effective-compliance-program-what-research-administrators-need-to-know/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/02/citi-program-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260929T151500 DTEND;TZID=America/New_York:20260929T161500 DTSTAMP:20260901T155708Z CREATED:20260901T155708Z LAST-MODIFIED:20260901T155708Z UID:62654-1790694900-1790698500@about.citiprogram.org SUMMARY:Free Webinar Replay - Navigating the Intersection of Open Science and Responsible Conduct of Research DESCRIPTION:Navigating the Intersection of Open Science and Responsible Conduct of Research\nTuesday\, September 29\, 2026 at 3:15 p.m. ET\nThis previously released webinar serves as an introduction to open science principles and practices. It describes what open science is\, how it is related to frameworks for Responsible Conduct of Research\, and the primary rationale for why it is valuable. It then reviews a set of core open science practices—open data\, open code\, open materials\, preregistration\, and open access publishing—highlighting both the benefits and potential limitations of each. The webinar emphasizes that engaging in open science practices is not “all or nothing” and is something that researchers can — and should — begin right away. \nRegister for additional free live webinars and available webinar replays. \n\n \n \n\n\n \n\n \n \n \n \n Register For This Webinar\n \n \n \n \n\n\n \n \n \n \n First Name\n \n \n \n \n \n Last Name\n \n \n \n \n\n \n \n \n Email Address\n \n \n \n \n \n Organization\n \n \n \n\n \n\n \n \n \n Please share your question for the presenter(s) here:\n \n \n \n \n\n \n \n \n May we contact you about new CITI Program content and services after the webinar?\n \n \n \n \n Yes\n \n \n \n No\n \n \n\n \n \n\n \n Register Now\n \n\n \n Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy. URL:https://about.citiprogram.org/event/free-webinar-replay-navigating-the-intersection-of-open-science-and-responsible-conduct-of-research/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2021/11/citi-program-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261007T120000 DTEND;TZID=America/New_York:20261007T130000 DTSTAMP:20260828T133341Z CREATED:20260828T133341Z LAST-MODIFIED:20260828T133341Z UID:63165-1791374400-1791378000@about.citiprogram.org SUMMARY:Clinical Center Ethics Grand Rounds: Ethics Of Reducing the Use of Animals In Research DESCRIPTION:Join the NIH for the “Clinical Center Ethics Grand Rounds: Ethics Of Reducing the Use of Animals In Research” session on October 7\, 2026. This session will be presented by Jayantha Bhattacharya\, MD\, Director at the National Institutes of Health. \nVisit the event page for more information. URL:https://about.citiprogram.org/event/clinical-center-ethics-grand-rounds-ethics-of-reducing-the-use-of-animals-in-research/ LOCATION:Main NIH Campus; Building 10 (Clinical Center); Lipsett Amphitheater\, 10 Center Drive\, Bethesda\, MD\, 20892\, United States ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/09/nih-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261007T130000 DTEND;TZID=America/New_York:20261007T140000 DTSTAMP:20260828T135800Z CREATED:20260828T135800Z LAST-MODIFIED:20260828T135800Z UID:63168-1791378000-1791381600@about.citiprogram.org SUMMARY:Town Hall – Biocompatibility and Toxicological Risk Assessment DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a town hall for industry stakeholders and other interested parties to discuss toxicological risk assessments used to address biocompatibility endpoints for medical devices. The session will focus on methods and considerations for conducting toxicological risk assessments in accordance with FDA-recognized standards\, as well as examples of common deviations encountered during the evaluation process. \nVisit the event page for more information. URL:https://about.citiprogram.org/event/town-hall-biocompatibility-and-toxicological-risk-assessment/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/04/fda-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261007T150000 DTEND;TZID=America/New_York:20261007T160000 DTSTAMP:20260828T132043Z CREATED:20260828T132043Z LAST-MODIFIED:20260828T132043Z UID:63163-1791385200-1791388800@about.citiprogram.org SUMMARY:Beyond the Lab: Insights into Clinical Development in Pharma DESCRIPTION:Join the NIH for the “Beyond the Lab: Insights into Clinical Development in Pharma” workshop\, presented by Delphine Lissa\, on October 7\, 2026. This webinar is part of NCI’s Science-Based Non-Academic Careers (SNAC) virtual workshop series\, which assists fellows\, staff scientists\, and staff clinicians in exploring non-academic career paths with greater clarity and confidence. \nVisit the event page for more information. URL:https://about.citiprogram.org/event/beyond-the-lab-insights-into-clinical-development-in-pharma/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/09/nih-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261014T120000 DTEND;TZID=America/New_York:20261014T130000 DTSTAMP:20260902T154920Z CREATED:20260902T154920Z LAST-MODIFIED:20260902T154920Z UID:63199-1791979200-1791982800@about.citiprogram.org SUMMARY:Navigating the FDA Bayesian Draft Guidance: Design\, Analysis\, and Review Considerations DESCRIPTION:Hosted by the FDA’s Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (SBIA)\, this event focuses on the Agency’s January 2026 draft guidance\, “Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products\,” which was published to address a PDUFA VII commitment. The guidance outlines key considerations for applying Bayesian methods in clinical trials\, including success criteria and operating characteristics\, the use of external information in prior distributions\, estimands and missing data\, software and computational considerations\, and the documentation and reporting of Bayesian analyses. \nThe program begins with a required pre-recorded video that participants may complete at their own pace before the live panel discussion. The recording provides an overview of the guidance and its implications for the design of clinical trials that use Bayesian methodologies. \nIntended Audience \nClinical trial professionals\, regulatory science professionals\, or regulatory affairs professionals involved in clinical trials and studies where Bayesian approaches may be used. \nTopics Covered \n\nA brief introduction to Bayesian approaches\nSuccess criteria and operating characteristics in Bayesian trials\nConsiderations for prior distributions\nAdditional topics including missing data and estimands\, software usage\, documenting and reporting expectations for Bayesian analyses\nDescriptions of specific settings where Bayesian methods have been previously used.\n\nVisit the event page for more information. URL:https://about.citiprogram.org/event/navigating-the-fda-bayesian-draft-guidance-design-analysis-and-review-considerations/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/04/fda-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261104T150000 DTEND;TZID=America/New_York:20261104T160000 DTSTAMP:20260930T135952Z CREATED:20260930T135952Z LAST-MODIFIED:20260930T135952Z UID:63527-1793804400-1793808000@about.citiprogram.org SUMMARY:Science-Based Non-Academic Careers (SNAC) Workshop: From Postdoc to CEO DESCRIPTION:Join the NIH for the “From Postdoc to CEO” workshop\, presented by Andrew Sinkoe\, Founder and CEO of Sesh Incorporated. This webinar will take place on November 4\, 2026. NCI’s SNAC workshop series provides fellows\, staff scientists\, and staff clinicians with insights and guidance to navigate non-academic career pathways. \nVisit the event page for more information. URL:https://about.citiprogram.org/event/science-based-non-academic-careers-snac-workshop-from-postdoc-to-ceo/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/09/nih-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261110T140000 DTEND;TZID=America/New_York:20261110T150000 DTSTAMP:20260930T134737Z CREATED:20260930T134737Z LAST-MODIFIED:20260930T134737Z UID:63525-1794319200-1794322800@about.citiprogram.org SUMMARY:NIH OBSSR Director’s Webinar: Extending Human Healthspan: Considering Psychosocial Drivers of Healthy Aging DESCRIPTION:Join the NIH for its upcoming webinar\, “Extending Human Healthspan: Considering Psychosocial Drivers of Healthy Aging.” This presentation will explore the role that psychosocial factors play in health and aging. As populations continue to live longer\, researchers are increasingly examining how both negative experiences\, such as social stress\, and positive psychological and social factors may influence health outcomes over time. The session will review epidemiological evidence linking these factors to chronic disease\, overall well-being\, and the aging process. \nKey topics include: \n\nResearch on the relationship between psychosocial factors and long-term health\nPotential mechanisms through which social and psychological experiences may affect physical health and aging\nStrategies and approaches that may help support healthy aging\n\nThis webinar will be presented by Laura Kubzansky\, PhD\, Harvard T.H. Chan School of Public Health. \nThe event is open to the public and will conclude with an opportunity for audience questions and discussion. Attendees will gain insight into current research examining the connections between social experiences\, psychological well-being\, and healthy aging. \nVisit the event page for more information. URL:https://about.citiprogram.org/event/nih-obssr-directors-webinar-extending-human-healthspan-considering-psychosocial-drivers-of-healthy-aging/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/09/nih-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261110T140000 DTEND;TZID=America/New_York:20261110T150000 DTSTAMP:20260930T142922Z CREATED:20260930T142922Z LAST-MODIFIED:20260930T142922Z UID:63534-1794319200-1794322800@about.citiprogram.org SUMMARY:NIST Small Business Cybersecurity Community of Interest Call DESCRIPTION:The National Institute of Standards and Technology (NIST) Small Business Cybersecurity Community of Interest (COI) brings together public and private sector participants to share insights\, challenges\, expertise\, and perspectives related to small business cybersecurity. The group helps inform NIST’s work to address the cybersecurity needs of the small business community. \nQuarterly COI meetings provide: \n\nUpdates on NIST’s small business program\nTopical discussions\nOpportunities for audience questions and engagement\n\nVisit the event page for more information. URL:https://about.citiprogram.org/event/nist-small-business-cybersecurity-community-of-interest-call/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2026/09/nist-small-business-cybersecurity.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261119T090000 DTEND;TZID=America/New_York:20261119T160000 DTSTAMP:20260930T140921Z CREATED:20260930T140835Z LAST-MODIFIED:20260930T140921Z UID:63529-1795078800-1795104000@about.citiprogram.org SUMMARY:Microbiology Devices Panel of the Medical Devices Advisory Committee Meeting Announcement DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a hybrid meeting of the Microbiology Devices Panel of the Medical Devices Advisory Committee on November 19\, 2026. The committee will discuss the scientific\, clinical\, and public health considerations surrounding the use of pathogen-agnostic sequencing in emergency preparedness and response efforts. The session will also examine opportunities\, implementation considerations\, and potential priorities for future coordination related to these technologies. \nThe meeting will be open to the public and held in both in-person and virtual formats. Public comments will also be accepted through an FDA-established docket. \nVisit the event page for more information. URL:https://about.citiprogram.org/event/microbiology-devices-panel-of-the-medical-devices-advisory-committee-meeting-announcement/ LOCATION:Online ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/04/fda-logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20261202T100000 DTEND;TZID=America/New_York:20261203T160000 DTSTAMP:20260930T141843Z CREATED:20260930T141843Z LAST-MODIFIED:20260930T141843Z UID:63532-1796205600-1796313600@about.citiprogram.org SUMMARY:Public Workshop: Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a hybrid\, two-day public workshop focused on autonomous and remote teleoperated robotic medical devices. The event will bring together a broad range of stakeholders\, including device manufacturers\, regulatory professionals\, healthcare providers\, patients\, and members of the public\, to discuss experiences with robotic technologies designed to interact with patients. The workshop aims to support dialogue on the benefits\, risks\, and real-world considerations associated with these evolving medical devices. \nWorkshop Objectives: \n\nFoster dialogue among stakeholders on terminology and key technical considerations for robotic medical devices with autonomous and/or remote teleoperation capabilities.\nBetter understand the probable benefits and risks of robotic medical devices with autonomous and/or remote teleoperation capabilities.\nExplore considerations for future policy development responsive to innovation while maintaining reasonable assurance of safety and effectiveness.\n\nThe workshop builds on the FDA’s longstanding engagement with the robotic medical device community and reflects ongoing efforts to better understand emerging technologies. The event will explore challenges and opportunities associated with advancing robotic medical devices while informing future regulatory and public health considerations. \nVisit the event page for more information. URL:https://about.citiprogram.org/event/public-workshop-evaluating-benefit-risk-in-robotic-medical-devices-with-autonomous-or-remote-teleoperation-capabilities/ LOCATION:FDA White Oak Campus: The Great Room\, Building 31\, 10903 New Hampshire Avenue\, Silver Spring\, MD\, 20993\, United States ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/04/fda-logo.png END:VEVENT END:VCALENDAR